FTRE
Price
$6.54
Change
-$0.01 (-0.15%)
Updated
Aug 6, 04:34 PM (EDT)
Capitalization
593.94M
Earnings call today
SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
Interact to see
Advertisement

FTRE vs SLXN

Header iconFTRE vs SLXN Comparison
Open Charts FTRE vs SLXNBanner chart's image
Fortrea Holdings
Price$6.54
Change-$0.01 (-0.15%)
Volume$2.83K
Capitalization593.94M
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
FTRE vs SLXN Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. SLXN commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (FTRE: $6.56 vs. SLXN: $8.86)
Brand notoriety: FTRE and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 109% vs. SLXN: 38%
Market capitalization -- FTRE: $593.94M vs. SLXN: $5.13M
FTRE [@Biotechnology] is valued at $593.94M. SLXN’s [@Biotechnology] market capitalization is $5.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • FTRE’s TA Score: 6 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than SLXN.

Price Growth

FTRE (@Biotechnology) experienced а +3.14% price change this week, while SLXN (@Biotechnology) price change was -28.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($594M) has a higher market cap than SLXN($5.13M). FTRE YTD gains are higher at: -64.826 vs. SLXN (-70.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. FTRE (-552.6M). SLXN has less debt than FTRE: SLXN (3.48M) vs FTRE (1.29B). FTRE has higher revenues than SLXN: FTRE (2.69B) vs SLXN (0).
FTRESLXNFTRE / SLXN
Capitalization594M5.13M11,570%
EBITDA-552.6M-16.96M3,259%
Gain YTD-64.826-70.61492%
P/E RatioN/AN/A-
Revenue2.69B0-
Total Cash102MN/A-
Total Debt1.29B3.48M36,933%
TECHNICAL ANALYSIS
Technical Analysis
FTRESLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
8%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 10 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACVUX10.49N/A
N/A
American Century International Value I
GSROX14.43N/A
N/A
Goldman Sachs Small Cap Gr Insghts R
BROCX20.66N/A
N/A
BlackRock Advantage International Inv C
VKSFX10.53N/A
N/A
Virtus KAR Small-Mid Cap Value I
TBWAX20.46-0.06
-0.29%
Thornburg Better World International A

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with VCEL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then VCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+2.18%
VCEL - FTRE
43%
Loosely correlated
-2.02%
SYRE - FTRE
41%
Loosely correlated
+4.39%
TECH - FTRE
41%
Loosely correlated
-0.44%
XNCR - FTRE
39%
Loosely correlated
N/A
JAZZ - FTRE
39%
Loosely correlated
-2.50%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More